GLP-1 Medication and Testosterone Levels Effects: A Comprehensive Guide
Testosterone plays a central role in endocrine and metabolic functions. Glucagon-like peptide-1 receptor agonists (GLP-1RAs), widely prescribed for type 2 diabetes and obesity, have been proposed to modulate testosterone levels. Although this association is not yet covered by clinical guidelines, emerging studies suggest favorable effects, possibly due to weight loss and improved metabolic homeostasis.
GLP-1 Medications and Testosterone Effects
Recent research has shown that GLP-1 agonist medications can significantly improve testosterone levels in men with obesity or type 2 diabetes. This effect is multifactorial, involving weight loss, improved metabolic homeostasis, and reduced aromatase activity. Studies have demonstrated that GLP-1 medications can restore ovulation in women with polycystic ovary syndrome (PCOS) by improving insulin sensitivity, suggesting that these medications may also positively affect hormone levels related to fertility.

How GLP-1 Medications Work
GLP-1 receptor agonists work by mimicking the natural hormone glucagon-like peptide-1 (GLP-1), which regulates blood sugar levels, appetite, and digestion. This hormone is released by the gut in response to eating and plays a crucial role in glucose metabolism. By mimicking GLP-1, GLP-1 agonist medications can help regulate appetite, slow digestion, and improve glucose control, leading to weight loss and improved metabolic health.